Reference health
Liraglutide modulates gut microbiota and reduces NAFLD in obese mice
47/47 checkable references clean · checked 2026-07-25
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 47 checked references that resolve
resolves10.1016/j.clinbiochem.2015.06.023
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
resolves10.1136/gutjnl-2012-303816
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
resolves10.1038/ismej.2014.45
Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity
resolves10.1021/jm9909645
Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration
resolves10.2337/diacare.24.9.1640
Impaired Incretin Response After a Mixed Meal Is Associated With Insulin Resistance in Nondiabetic Men
resolves10.1096/fj.14-265983
Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance
<i>via</i>
glucagon‐like peptide 1 in diet‐induced obesity
resolves10.1002/mnfr.201400871
Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon‐like peptide‐1 secretion
resolves10.1016/j.metabol.2003.08.011
Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients
resolves10.1111/j.2040-1124.2012.00214.x
Predicting efficacy of dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels
resolves10.1038/sj.bjp.0705397
GLP‐1 derivative liraglutide in rats with <i>β</i>‐cell deficiencies: influence of metabolic state on <i>β</i>‐cell mass dynamics
resolves10.2337/diacare.23.1.57
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
resolves10.1007/BF00257788
A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of langerhans
resolves10.1017/S0007114512004576
Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets
resolves10.1093/bioinformatics/btt526
Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data
resolves10.1002/hep.20701
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
resolves10.2337/db12-0649
Is Endogenous GLP-1 the Only Important Enhancer of Glucose-Induced Insulin Secretion in Type 2 Diabetes?
resolves10.1038/nature05414
An obesity-associated gut microbiome with increased capacity for energy harvest
resolves10.2174/1871530316666160831093813
Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss
resolves10.1016/j.celrep.2017.10.056
Dietary Uncoupling of Gut Microbiota and Energy Harvesting from Obesity and Glucose Tolerance in Mice
resolves10.1038/srep33251
Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
resolves10.1177/1535370217743765
Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats
resolves10.1111/j.1463-1326.2012.01579.x
Non‐glycaemic effects mediated via GLP‐1 receptor agonists and the potential for exploiting these for therapeutic benefit: focus on liraglutide
resolves10.1530/JOE-16-0478
The effects of liraglutide in mice with diet-induced obesity studied by metabolomics
resolves10.4161/gmic.1.4.12778
Mucin-bacterial interactions in the human oral cavity and digestive tract
resolves10.1073/pnas.1006451107
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions
resolves10.1159/000358156
Mucosal Barrier, Bacteria and Inflammatory Bowel Disease: Possibilities for Therapy
resolves10.1053/j.gastro.2016.02.073
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
resolves10.1002/hep.26093
Characterization of Gut Microbiomes in Nonalcoholic Steatohepatitis (NASH) Patients: A Connection Between Endogenous Alcohol and NASH
resolves10.1074/jbc.M113.452516
Beneficial Metabolic Effects of a Probiotic via Butyrate-induced GLP-1 Hormone Secretion
resolves10.1186/s13059-016-1052-7
Heritable components of the human fecal microbiome are associated with visceral fat
resolves10.1002/hep.28572
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach
resolves10.1016/j.cmet.2017.04.001
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
resolves10.1136/gutjnl-2016-312431
Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
resolves10.1111/dom.12748
Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
The 4 references without a DOI — listed, not checked
no DOI — not checkedGut microflora as a target for energy and metabolic homeostasis
no DOI — not checkedObesity alters the microbial community profile in Korean adolescents
no DOI — not checkedHelicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice
no DOI — not checked10.1016/j.jnutbio.2018.07.009_bb0250
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-25 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.jnutbio.2018.07.009"><img src="https://citestamp.com/citestamped/10.1016/j.jnutbio.2018.07.009/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.jnutbio.2018.07.009)